Related by context. All words. (Click for frequent words.) 70 AEZS 69 ARRY 67 AEGR 66 ATHX 66 NKTR 65 ALTU 65 IDX# 65 ALKS 64 HCV protease inhibitor 64 MEDI 63 HGSI 63 AVNR 62 JAK inhibitor 62 Viramidine 62 SCH # 62 CRx 62 NBIX 62 ANX 62 IMMU 62 CUDC 61 ONXX 61 INCY 61 DVAX 61 axitinib 61 bevirimat 61 Immunogen 61 pomalidomide 61 integrase inhibitor 61 Reverset 61 Vertex Pharma 61 BIOD 61 ACHN 61 ganetespib 60 MDVN 60 Cethromycin 60 polymerase inhibitor 60 bendamustine 60 KERX 60 IDIX 60 INGN 60 MNKD 60 Seattle Genetics SGEN 60 celgosivir 60 VRTX 60 SVNT 60 INCB# [001] 60 PEG Interferon lambda 60 elvitegravir 60 ritonavir boosted 60 SGEN 60 Laquinimod 60 Phase 1b 60 Traficet EN 60 PRTX 59 Telaprevir 59 oritavancin 59 ALXA 59 ocrelizumab 59 Bicifadine 59 Phase Ib 59 Zalbin 59 virus HCV protease inhibitor 59 aleglitazar 59 HCV protease 59 CCR5 antagonist 59 elotuzumab 59 Thiovir 59 maraviroc 59 XmAb# 59 telaprevir VX 59 PegIntron 59 ixabepilone 59 AUXL 59 non nucleoside inhibitor 59 daclizumab 59 ONTY 59 BAY #-# 59 BPAX 59 valopicitabine 59 Allos Therapeutics ALTH 59 Onyx Pharma 59 pradefovir 59 glufosfamide 59 EXEL 59 Plicera 59 LymphoStat B 59 IMGN 59 Bezielle 59 PEG SN# 59 lintuzumab 58 Phenoptin 58 phase IIb clinical 58 vicriviroc 58 Phase 1b trial 58 subcutaneously administered 58 Acadia Pharmaceuticals 58 Vernakalant 58 pegylated interferon alpha 58 oral prodrug 58 Exelixis EXEL 58 HuMax CD4 58 evaluating tivozanib 58 Pharmasset 58 PRX # 58 CRTX 58 radezolid 58 VEGF Trap 58 Carfilzomib 58 GSK# [001] 58 sunitinib malate 58 ISENTRESS 58 cilengitide 58 aflibercept 58 LY# [003] 58 Idenix Pharmaceuticals 58 PEG PAL 58 Actilon 58 nitazoxanide 58 CRXX 58 MNTX 58 protease inhibitor 58 Asentar 58 liposomal formulation 58 CLDX 58 ALNY 58 Tyrima 58 ZIOP 58 Guanilib 58 danoprevir 58 BMY 58 nucleoside analog 58 ZGEN 58 tasimelteon 58 iniparib 58 Phase Ib clinical 58 transcriptase inhibitor NNRTI 58 velafermin 58 MAXY alpha 58 TMC# [001] 58 Arqule 58 SUPG 58 ISPH 58 Regeneron Pharma 58 ISIS # 58 DepoMed 58 GALNS 58 Gralise 58 viral kinetic 58 GNVC 58 HCV protease inhibitors 58 PS# [001] 57 Pegasys plus Copegus 57 VNDA 57 QCOR 57 VVUS 57 CR# vcMMAE 57 favorable pharmacokinetic profile 57 rNAPc2 57 PXD# 57 Albuferon 57 indacaterol 57 Tarvacin 57 antiviral activity 57 LY# [002] 57 pegylated interferons 57 pramlintide 57 administered subcutaneously 57 alvespimycin 57 NVA# 57 Ardea Biosciences 57 Copegus ribavirin 57 Nuvion 57 TACI Ig 57 darunavir 57 Corlux 57 Progenics Pharmaceuticals 57 MOGN 57 Bristol Myers BMY 57 REGN 57 NASDAQ REGN 57 Epivir 57 ABIO 57 mapatumumab 57 RPRX 57 rilpivirine 57 HuMax EGFr 57 dirucotide 57 otelixizumab 57 RDEA# 57 phase Ib 57 Phase 2a trial 57 CoFactor 57 Ridaforolimus 57 dacetuzumab 57 AMRN 57 elvucitabine 57 Rigel Pharmaceuticals 57 XNPT 57 pegylated interferon alpha 2a 57 bicifadine 57 VPHM 57 SLXP 57 Serdaxin 57 SOMX 57 Phase Ib study 57 VICL 57 CXA 57 ENZN 57 Acadia Pharmaceuticals ACAD 57 Cephalon NASDAQ CEPH 57 Velcade bortezomib 57 HspE7 57 decitabine 57 RG# [001] 57 Omacetaxine 57 eniluracil 57 Debio 57 Elvitegravir 57 tezampanel 56 HuMax CD# 56 GENZ 56 visilizumab 56 Restanza 56 Phase 2b 56 Amigal 56 MEK inhibitor 56 Isis Pharmaceuticals ISIS 56 midstage clinical 56 perifosine 56 POZN 56 Inhibitex INHX 56 RVX 56 MYGN 56 amrubicin 56 RXII 56 phase IIa 56 MYRX 56 Cinquil 56 PRT# 56 GSK# [002] 56 Phase IIa clinical 56 LAF# 56 OREX 56 NS#/#A protease 56 long acting muscarinic 56 ARQL 56 GENR 56 CRME 56 histone deacetylase HDAC inhibitor 56 orally bioavailable 56 Pimavanserin 56 ARIKACE 56 mipomersen 56 DSCO 56 carfilzomib 56 tanespimycin 56 Human Genome Sciences HGSI 56 IPL# 56 IMGN# 56 temsirolimus 56 pan HDAC inhibitor 56 YONDELIS 56 TSRX 56 mcg dose 56 albinterferon alfa 2b 56 tipranavir 56 Abiraterone acetate 56 Roche Pegasys 56 Mipomersen 56 XL# [003] 56 BCRX 56 linaclotide 56 BIIB 56 low dose ritonavir 56 Phase 2a 56 vismodegib 56 TELINTRA 56 S/GSK# 56 THRX 56 telaprevir 56 μg dose 56 Voreloxin 56 PF # [001] 56 ARYX 56 NRTI 56 anidulafungin 56 orally administered inhibitor 56 NASDAQ VRTX 56 Phase IIa trial 56 proteasome inhibitor 56 Ziopharm 56 Ariad Pharmaceuticals 56 PHRM 56 Maribavir 56 OPXA 56 BAL# [002] 56 compound ITMN 56 Relovair 56 Ramoplanin 56 lomitapide 56 teriflunomide 56 investigational compound 56 MDCO 56 lesinurad 56 enzastaurin 56 SAR# [004] 56 Apoptone 56 oral antiviral 56 BMRN 56 CIMZIA TM 56 RDEA 56 ALTH 56 voreloxin 56 Phase 1a 56 HGS ETR1 56 Darusentan 56 Bristol Myers Squibb BMY 56 PDE4 inhibitor 56 Ambrisentan 56 GTOP 56 Panzem R NCD 56 Hsp# inhibitors 56 PROMACTA 56 posaconazole 56 oral FTY# 56 Incyte 56 protease inhibitors 56 HuLuc# 56 bosutinib 56 neuraminidase inhibitor 56 Synavive 55 Tarceva TM 55 regorafenib 55 CCR5 receptor antagonist 55 Tezampanel 55 OPTR 55 Pafuramidine 55 blinded randomized placebo controlled 55 NGX# 55 ENMD 55 THLD 55 telbivudine 55 tocilizumab 55 CYTX 55 TRBN 55 Alkermes ALKS 55 Dendreon DNDN 55 antiviral efficacy 55 ponatinib 55 vilazodone 55 Sym# 55 Onyx Pharmaceuticals 55 Vicriviroc 55 PLX# 55 forodesine 55 Darunavir 55 Aurexis 55 Zerenex 55 Adventrx 55 MNTA 55 adefovir 55 pegylated interferon alfa 2a 55 belinostat 55 Nektar Therapeutics NKTR 55 Arena Pharmaceuticals ARNA 55 Blinatumomab 55 QVA# 55 Aflibercept 55 NASDAQ ONXX 55 nab paclitaxel 55 Phase 1b clinical 55 dexpramipexole 55 GERN 55 AFFY 55 Archexin 55 selective modulator 55 tecarfarin 55 viral kinetics 55 Pegasys peginterferon alfa 2a 55 Boceprevir 55 rilonacept 55 HGS ETR2 55 HZT 55 ceftaroline 55 torezolid 55 Optimer Pharmaceuticals 55 GLPG# 55 atacicept 55 DYAX 55 OGXI 55 phase IIb 55 Anadys Pharma 55 Affymax AFFY 55 SGMO 55 tenofovir disoproxil fumarate 55 raltegravir 55 Civacir 55 polymerase inhibitors 55 ANA# 55 AMGN 55 LGND 55 Phase IIb clinical 55 alfa 2a 55 Achillion 55 atazanavir sulfate 55 PSN# [002] 55 metreleptin 55 SRT# [003] 55 neratinib 55 nucleotide analogue 55 intravenous dosing 55 Keryx Biopharma 55 abacavir lamivudine 55 non nucleoside HCV 55 pralatrexate 55 Halozyme Therapeutics 55 MGCD# [001] 55 ritonavir boosted atazanavir 55 INCB# [002] 55 nucleoside 55 AP# [003] 55 nucleoside analogue 55 lixisenatide 55 VQD 55 INSM 55 cannabinor 55 Onyx Pharmaceuticals ONXX 55 SAR# [002] 55 Trexima 55 dose cohorts 55 MAGE A3 ASCI 55 BMS # 55 INHX 55 EPCT 55 Entremed 55 TMC# [002] 55 Pegintron 55 ISTODAX 55 Phase IIb trials 55 confirmatory Phase 3 55 protease inhibitor PI 55 blinatumomab 55 HDAC Inhibitor 55 DermaVir Patch 55 APTIVUS r 55 atrasentan 55 Hematide 55 Phase 2b study 55 Phase 2b trial 55 PSMA ADC 55 HCD# [002] 55 CEPH 55 Nexavar ® 55 EYET 55 telcagepant 55 Æterna Zentaris 55 dose cohort 55 Peregrine Pharma 55 Selzentry 55 CA4P 55 preclinical studies 55 MEDX 55 LEVADEX 55 Phase Ib II 55 Antiviral Activity 55 Triolex 55 Aptivus ® 55 Tasimelteon 55 Vectibix panitumumab 55 T DM1 55 EndoTAG TM -1 55 HGS# 55 MEK inhibitors 55 abiraterone 55 Hsp# inhibitor 55 CYTR 55 Telintra 55 MT# MEDI 55 antisense drug 55 Abbott ABT 54 inhibitor RG# 54 antiplatelet agent 54 zanolimumab 54 AEG# 54 Symadex 54 tolerability profiles 54 Phase 2b clinical 54 Febuxostat 54 NASDAQ ANDS 54 refractory CLL 54 Sanctura XR 54 ritonavir boosting 54 elagolix 54 Phase IIb 54 NLTX 54 Phase IIb trial 54 obatoclax 54 sorafenib tablets 54 methylnaltrexone 54 preclinical efficacy 54 DRRX 54 Ceflatonin 54 MIRCERA 54 AMLN 54 Alnylam ALNY 54 Telbivudine 54 MLNM 54 docetaxel Taxotere R 54 tasocitinib 54 HIV integrase inhibitor 54 FTY# 54 BCX# 54 APTIVUS 54 Gilead GILD 54 experimental hepatitis C 54 Human Genome HGSI 54 adecatumumab 54 ZOLINZA 54 Targretin 54 Perifosine 54 BMN 54 oral ridaforolimus 54 Rebetol 54 Clevudine 54 phase IIa clinical 54 CCX# B 54 BARACLUDE R 54 midstage trials 54 ambrisentan 54 CCX# 54 SNTS 54 Exelixis XL# 54 sapacitabine 54 denufosol 54 Avanir Pharmaceuticals AVNR 54 Ceplene/IL-2 54 pertuzumab 54 eResearchTechnology 54 Pharmion PHRM 54 apremilast 54 oral Hsp# inhibitor 54 Peginterferon 54 ipilimumab 54 registrational 54 multiple ascending dose 54 Sorafenib 54 NNRTIs 54 MyVax 54 TTHI 54 hepatitis C protease inhibitor 54 Phase Ia 54 ENCY 54 VAPRISOL 54 Vertex Pharmaceuticals Inc 54 abiraterone acetate 54 investigational oral 54 eltrombopag 54 PCK# 54 Onyx Pharmaceuticals Inc 54 targeting CD# 54 L BLP# 54 maximally tolerated dose 54 Glufosfamide 54 Vectibix 54 Phase III clinical 54 Oritavancin 54 Alpharadin 54 Nanobody ® 54 davunetide intranasal AL 54 mg dose 54 maturation inhibitor 54 epothilone 54 aclidinium 54 huC# DM4 54 CCR5 mAb 54 cethromycin 54 deforolimus 54 Cyclacel Pharmaceuticals 54 alvimopan 54 preclinically 54 NXL# 54 KNS # 54 investigational humanized monoclonal antibody 54 Lu AA# 54 LymphoStat B TM 54 DU #b 54 fostamatinib 54 Phase Ib clinical trials 54 amprenavir 54 interferon alfa 54 ridaforolimus 54 darunavir ritonavir 54 solithromycin 54 alpha 2a 54 Xenoport 54 Panzem 54 pharmacodynamic properties 54 Penwest Pharmaceuticals 54 thiazolides 54 RSD# 54 vernakalant 54 XOMA 54 Neurocrine Biosciences NBIX 54 Allovectin 7 54 alefacept 54 AZILECT R 54 ascending doses 54 InterMune 54 Biosante Pharmaceuticals 54 GSK '# 54 Somaxon Pharmaceuticals 54 MDV# 54 JAK2 inhibitor 54 ozarelix 54 ELND# 54 NSTK 54 Fodosine 54 metastatic renal cell carcinoma 54 AGIX 54 EXAS 54 Anadys Pharmaceuticals 54 investigational oral hepatitis C 54 DCTH 54 Tipranavir 54 PREZISTA r 54 Gilead Sciences GILD 54 BARACLUDE ® 54 Keryx Biopharmaceuticals 54 vosaroxin 54 bifeprunox 54 iCo 54 pegylated 54 Pegasys ® 54 lurasidone 54 Alexion Pharmaceuticals ALXN 54 tesmilifene 54 picoplatin 54 compound INCB# 54 Immunomedics IMMU 54 Icatibant 54 monotherapy 54 OHR/AVR# 54 Vilazodone 54 RSR# 54 Nasdaq VRTX 54 baminercept 54 natalizumab 54 NASDAQ SGEN 54 metaglidasen 54 CCR5 inhibitor 53 relapsed refractory multiple myeloma 53 CAELYX 53 Elotuzumab 53 investigational hepatitis C 53 bortezomib 53 Maraviroc 53 mertansine 53 Amrubicin 53 ruxolitinib 53 DPP4 inhibitor 53 Menerba 53 apricitabine 53 Phase IIa trials 53 TG# [003] 53 midstage studies 53 Vertex Pharmaceuticals NASDAQ VRTX 53 ARNA 53 Idenix Pharmaceuticals Inc. 53 subcutaneous formulation 53 Marqibo 53 diabetic neuropathic pain 53 fosamprenavir 53 dalbavancin 53 BCR ABL inhibitors 53 relapsing remitting multiple sclerosis 53 Ceflatonin R 53 ProSavin 53 corticosteroid dexamethasone 53 Incyte INCY 53 Telavancin 53 CADX 53 Aptivus 53 Entecavir 53 INC# 53 Dasatinib 53 Rexahn Pharmaceuticals 53 Crizotinib 53 PD LID 53 Amylin AMLN 53 Targacept TRGT 53 OncoVEX GM CSF 53 Celgene CELG 53 Sapacitabine 53 Dificid 53 initiate Phase 1b 53 Epothilone D 53 Vertex VRTX 53 lapatinib Tykerb 53 Questcor Pharmaceuticals QCOR 53 SCLN 53 elesclomol 53 TBC# 53 Dalbavancin 53 Dapagliflozin 53 MORAb 53 PegIFN RBV 53 HCV polymerase inhibitors 53 LCP Tacro 53 Ecallantide 53 CLDA 53 peginterferon alfa 2b 53 NASDAQ MNKD 53 Vertex Pharmaceuticals VRTX 53 dextromethorphan quinidine 53 IND enabling 53 ASONEP 53 rindopepimut 53 Idenix 53 maribavir 53 Nexavar 53 RhuDex ® 53 ZYBRESTAT 53 Horizant 53 Phase IIIb clinical 53 Phase IIa 53 OSI Pharmaceuticals OSIP 53 Synta Pharmaceuticals 53 IMC A# 53 EOquin 53 TriRima 53 phase IIb study 53 rifapentine 53 enfuvirtide 53 Momenta Pharmaceuticals 53 PRADAXA 53 vemurafenib 53 KSP inhibitor 53 histone deacetylase inhibitor 53 rituximab Rituxan 53 peginterferon alfa 2a 53 sorafenib Nexavar 53 Golimumab 53 Telcyta 53 ImmunoVEX HSV2 53 active comparator 53 Auxilium Pharmaceuticals 53 Curagen 53 4SC 53 cangrelor 53 satraplatin 53 Eltrombopag 53 Panacos 53 pivotal Phase III 53 chronic HCV infection 53 preclinical 53 Arcalyst 53 INVIRASE 53 PEGASYS ® 53 trodusquemine 53 volociximab 53 ketolide antibiotic 53 Avanafil 53 lumiliximab 53 investigational protease inhibitor 53 CDP# 53 Taspoglutide 53 Vanda Pharmaceuticals Inc. 53 Cytokinetics CYTK 53 Ozarelix 53 lupus nephritis 53 LLY 53 KV.A 53 CRXL 53 Forest Laboratories FRX 53 Tesmilifene 53 Neurodex 53 docetaxel chemotherapy 53 thymalfasin 53 SGXP 53 fosbretabulin 53 thrombopoietin 53 edoxaban 53 denosumab 53 pharmacodynamic 53 Dendreon Provenge 53 amphotericin B 53 milatuzumab 53 Vertex telaprevir 53 CBST 53 Intelence 53 Dynavax Technologies 53 nucleotide analog 53 MannKind MNKD 53 SARMs 53 pharmacokinetic interactions 53 Fibrillex TM 53 BRAF inhibitor 53 bortezomib Velcade R 53 registrational trial 53 DB# [003] 53 Fc fusion protein 53 Amgen AMGN 53 Bristol Myers NYSE BMY 53 Azixa 53 Atherogenics 53 panitumumab 53 Nasdaq SLXP 53 Albuferon TM 53 Peg IFN 53 entecavir 53 tenofovir Viread 53 dose regimens 53 seliciclib 53 EVIZON 53 Hsp# Inhibitor 53 CEQ# 53 peginterferon alpha 2a 53 doripenem 53 Medarex MEDX 53 Satraplatin 53 iloperidone 53 Androxal TM 53 sorafenib 53 Nasdaq RDEA 53 TRACON Pharmaceuticals 53 darapladib 53 budesonide foam 53 Phase 1a clinical 53 chronic hepatitis C 53 SQNM 53 AZT zidovudine Retrovir 53 nucleoside analogues 53 Zybrestat 53 rFIXFc 53 ATL# [001] 53 Daclizumab 53 Cubist Pharmaceuticals Inc 53 Depomed DEPO 53 CYPB 53 TRIOLEX 53 tivozanib 53 velafermin belinostat 53 peg interferon 53 interferon gamma 1b 53 Xinlay 53 ELACYT 53 brivaracetam 53 Avanir 53 Panitumumab 53 NRTIs 53 integrase inhibitors 53 Oncothyreon Inc 53 Afresa 52 Protexia R 52 Anthim 52 Phase III trials 52 Onconase 52 Genz # 52 vidofludimus 52 NASDAQ CLDX 52 Muraglitazar 52 Zenvia Phase III 52 RNVS 52 Meets Primary Endpoint 52 alpha 2b 52 oral candidiasis 52 non nucleoside reverse 52 Rebif ® 52 Addex 52 exenatide LAR 52 Dacogen injection 52 Rigel Pharmaceuticals Inc. 52 DAVANAT 52 oral methylnaltrexone 52 rapid virologic response 52 NGSX 52 ILLUMINATE 52 EndoTAGTM 1 52 canakinumab 52 GED aPC 52 AEterna 52 pharmacokinetic profile 52 ALN RSV# 52 HCV SPRINT 52 Isentress raltegravir 52 Pharmacokinetics PK 52 Celgene Revlimid 52 rifabutin 52 NRTI resistance 52 Inc. NASDAQ ITMN 52 ulimorelin 52 eprotirome 52 pharmacokinetic PK study 52 Peregrine Pharmaceuticals 52 Kuvan 52 reslizumab 52 Tamibarotene 52 phase IIb trial 52 OXi# 52 HBeAg positive 52 Biogen Idec BIIB 52 pirfenidone 52 Annamycin 52 Trubion Pharmaceuticals Inc. 52 mTOR inhibitor 52 CCR5 antagonists 52 ONCY 52 GW# [003] 52 RPTP 52 PEG interferon 52 phase 2a 52 OSIR 52 Phase IIB 52 Merck boceprevir 52 Genentech Roche 52 NASDAQ SNSS 52 Aurora kinase inhibitor 52 etravirine 52 Xeloda ® 52 cytokine refractory 52 ABII 52 LEXIVA 52 HCV 52 PI3K inhibitor 52 cidofovir 52 panitumumab Vectibix 52 MAA submission 52 REYATAZ R 52 LibiGel 52 Riquent 52 Eurand NV EURX 52 glatiramer acetate 52 recurrent glioblastoma multiforme 52 tigecycline 52 Nasdaq OPTR 52 KRN# 52 SCY 52 JANUVIA 52 transcriptase inhibitors 52 Fusilev 52 sunitinib 52 angiogenesis inhibitor 52 INKP 52 ruboxistaurin 52 Allovectin 7 ® 52 caspofungin 52 talactoferrin 52 betrixaban 52 peginesatide 52 cyclophilin inhibitor 52 Kaletra lopinavir ritonavir 52 PEG INTRON 52 Arranon 52 vandetanib 52 relapsed multiple myeloma 52 ongoing Phase 1b 52 systemically administered 52 Phase #b/#a 52 cabazitaxel 52 Nasulin 52 Tanespimycin 52 XL# XL# XL# XL# 52 Nasdaq CBST 52 orally administered 52 Relivar 52 immunomodulator 52 IMC #B 52 lamivudine 3TC 52 daptomycin 52 CELG 52 BNVI 52 Inspire Pharmaceuticals Inc 52 Fablyn 52 Radezolid 52 NYMX 52 Gilenia 52 TLCR 52 Liraglutide 52 ALXN 52 dasatinib 52 INTELENCE 52 NU# [001] 52 Randomized Phase 52 bazedoxifene 52 metastatic castration resistant 52 Initiate Phase 52 custirsen 52 Zolinza 52 relapsed MM 52 protease inhibitor telaprevir 52 intranasal formulation 52 Nasdaq ITMN 52 Cell Therapeutics CTIC 52 cetuximab Erbitux R 52 Ampligen R 52 dosing regimens 52 Adalimumab 52 OSIP 52 TSPT